Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis.
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 111 participants.
Also called NCT07524595
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 111 participants
- Registry
-
NCT07524595
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Ireland
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07524595. Randomized; no masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2027-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis.
- Acronym
- REVIVAL
- Condition
- AORTIC VALVE DISEASES
- Condition
- Valve-in-valve Procedures
- Condition
- Surgical Valve Replacement
- Condition
- Valve Disease, Aortic
- Intervention (Device)
- Hydra THV Series
- Intervention (Device)
- Sapien THV Series and MyVal THV Series
- Lead sponsor
- National University of Ireland, Galway, Ireland
Record details
- Record id
cardio:ct-nct07524595- Content hash
51aae7cf43d7505b3b84c206b96648379577490fc5ea8fa87f8788ff46285f36